ZA200800032B - Transdermal system for varenicline - Google Patents

Transdermal system for varenicline

Info

Publication number: ZA200800032B
Authority: ZA; South Africa
Prior art keywords: varenicline; transdermal system; transdermal
Prior art date: 2005-07-26

Application number

ZA200800032A

Other languages

English (en)

Inventor

Johnson Barbara Alice

Ziegler Carl Bernard

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-26

Filing date

2008-01-02

Publication date

2009-09-30

2008-01-02 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2009-09-30 Publication of ZA200800032B publication Critical patent/ZA200800032B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Dispersion Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Psychology (AREA)
Obesity (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA200800032A 2005-07-26 2008-01-02 Transdermal system for varenicline ZA200800032B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US70296105P	2005-07-26	2005-07-26

Publications (1)

Publication Number	Publication Date
ZA200800032B true ZA200800032B (en)	2009-09-30

Family

ID=37175751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200800032A ZA200800032B (en)	2005-07-26	2008-01-02	Transdermal system for varenicline

Country Status (17)

Country	Link
US (1)	US20110086086A1 (xx)
EP (1)	EP1909773B1 (xx)
JP (1)	JP2007031436A (xx)
KR (2)	KR20080018278A (xx)
CN (2)	CN101862310A (xx)
AR (1)	AR054507A1 (xx)
AT (1)	ATE524168T1 (xx)
AU (1)	AU2006273772A1 (xx)
BR (1)	BRPI0614171A2 (xx)
CA (1)	CA2616695C (xx)
IL (1)	IL188268A0 (xx)
MX (1)	MX2007016458A (xx)
NZ (1)	NZ564685A (xx)
RU (1)	RU2388461C2 (xx)
TW (1)	TWI327472B (xx)
WO (1)	WO2007012963A1 (xx)
ZA (1)	ZA200800032B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007058504A1 (de) *	2007-12-05	2009-07-09	Acino Ag	Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
ES2648197T3 (es) *	2008-02-27	2017-12-29	Hisamitsu Pharmaceutical Co., Inc.	Parche medicado
JP5546013B2 (ja) *	2008-02-27	2014-07-09	久光製薬株式会社	貼付剤及び包装体
WO2009111623A2 (en) *	2008-03-06	2009-09-11	Dr. Reddy's Laboratories Ltd.	Amorphous varenicline tartrate
WO2009143347A2 (en)	2008-05-22	2009-11-26	Teva Pharmaceutical Industries Ltd.	Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
JP2010285415A (ja) *	2009-06-15	2010-12-24	Hisamitsu Pharmaceut Co Inc	バレニクリン又は薬学的に許容されるバレニクリン酸付加塩を含有する経皮薬物送達システムの包装体
WO2010151524A1 (en)	2009-06-22	2010-12-29	Teva Pharmaceutical Industries Ltd	Solid states forms of varenicline salts and processes for preparation thereof
US20110274628A1 (en)	2010-05-07	2011-11-10	Borschke August J	Nicotine-containing pharmaceutical compositions
CN102541332A (zh) *	2010-12-30	2012-07-04	联咏科技股份有限公司	单击手势判断方法、触控感应控制芯片、触控及电脑系统
US20130053668A1 (en) *	2011-08-26	2013-02-28	Compose Element Limited	Kit and method for detecting blood sugar
JP6324964B2 (ja) *	2013-08-23	2018-05-16	久光製薬株式会社	貼付剤
BR112017008097B1 (pt)	2014-10-20	2023-03-28	Oyster Point Pharma, Inc	Método para tratar condições oculares
DK3439661T3 (da)	2016-04-07	2021-10-18	Oyster Point Pharma Inc	Fremgangsmåder til behandling af øjenlidelser
KR102771688B1 (ko) *	2016-09-07	2025-02-20	에스케이케미칼 주식회사	바레니클린의 경피 투여를 위한 약학 제제
GB2561333B (en)	2017-02-17	2020-06-03	Bo Soederpalm	Treatment of alcohol use disorder
US10912734B2 (en) *	2018-05-16	2021-02-09	Cipla Limited	Depot formulation
CN111135087A (zh) *	2020-01-09	2020-05-12	范小玲	一种溶剂型透皮贴的工业化制备方法
US12201732B2 (en) *	2020-12-23	2025-01-21	Game Changer Patch Co.	Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement
CN113116814A (zh) *	2021-04-01	2021-07-16	江苏山信药业有限公司	一种伐尼克兰透皮溶液剂及其制备方法和其应用
CN116370439A (zh) *	2022-04-01	2023-07-04	江苏山信药业有限公司	一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US127531A (en) *		1872-06-04		Improvement in car-starters
US219196A (en) *		1879-09-02		Improvement in bretzel-machines
US4910020A (en) *	1988-10-21	1990-03-20	Macrochem Corporation	Transdermal medicator
DE3910578A1 (de) *	1989-03-29	1990-10-04	Schering Ag	Mittel zur transdermalen applikation enthaltend gestoden
ES2081823T3 (es) *	1988-10-27	1996-03-16	Schering Ag	Agente para la aplicacion transdermica, que contiene gestoden.
US5008110A (en) *	1988-11-10	1991-04-16	The Procter & Gamble Company	Storage-stable transdermal patch
WO1995007078A1 (en) *	1993-09-10	1995-03-16	Cytomed, Inc.	Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US5552399A (en) *	1994-11-02	1996-09-03	Janssen Pharmaceutica N.V.	Substituted tetracyclic azepine derivatives
US6365178B1 (en) *	1996-09-06	2002-04-02	Watson Pharmaceuticals, Inc.	Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
IT1294748B1 (it) *	1997-09-17	1999-04-12	Permatec Tech Ag	Formulazione per un dispositivo transdermico
EP1041975B1 (en) *	1997-12-22	2002-09-04	Alza Corporation	Rate controlling membranes for controlled drug delivery devices
JP2003520191A (ja) *	1998-09-08	2003-07-02	ワトソンファーマシューティカルズ，インコーポレイテッド	薬物の親水性塩類を含有する感圧接着剤マトリックスパッチの製造方法
EA005528B1 (ru) *	2001-05-14	2005-04-28	Пфайзер Продактс Инк.	Тартраты 5,8,14-триазатетрацикло[10.3.1.02,11.04,9]гексадека-2(11),3,5,7,9-пентаена
US20030008892A1 (en) *	2001-07-09	2003-01-09	Pfizer Inc.	Pharmaceutical composition and method of modulating cholinergic function in a mammal
DE10141651B4 (de) *	2001-08-24	2007-02-15	Lts Lohmann Therapie-Systeme Ag	Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE60209929T2 (de) *	2001-11-29	2006-11-16	Pfizer Products Inc., Groton	Succinatsalze von 58;8;14-triatetracyclo[10.3.1.0 2,11 .0 4,9]-hexadeca-2,11,3,5,7,9,-pentaen und pharmazeutische zusammensetzungen
AU2002351008B2 (en) *	2001-11-30	2007-07-12	Pfizer Products Inc.	Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US6676961B1 (en) *	2002-03-06	2004-01-13	Automated Carrier Technologies, Inc.	Transdermal patch assembly
AU2003250106B2 (en) *	2002-07-18	2009-11-26	Cytos Biotechnology Ag	Hapten-carrier conjugates comprising virus like particles and uses thereof
CA2583101A1 (en) *	2004-10-15	2006-04-20	Pfizer Products Inc.	Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
WO2006049941A2 (en) *	2004-10-27	2006-05-11	Neurogen Corporation	Diaryl ureas as cb1 antagonists
JP2008526827A (ja) *	2005-01-07	2008-07-24	ファイザー・プロダクツ・インク	５，８，１４−トリアザテトラシクロ［１０．３．１．０２，１１．０４，９］−ヘキサデカ−２（１１），３，５，７，９−ペンタエンの速崩壊性投与形態

2006
- 2006-06-13 US US11/574,045 patent/US20110086086A1/en not_active Abandoned
- 2006-07-13 RU RU2008101926/15A patent/RU2388461C2/ru not_active IP Right Cessation
- 2006-07-13 CN CN201010115865A patent/CN101862310A/zh active Pending
- 2006-07-13 KR KR1020087002048A patent/KR20080018278A/ko not_active Withdrawn
- 2006-07-13 CA CA2616695A patent/CA2616695C/en not_active Expired - Fee Related
- 2006-07-13 MX MX2007016458A patent/MX2007016458A/es active IP Right Grant
- 2006-07-13 EP EP06779913A patent/EP1909773B1/en not_active Not-in-force
- 2006-07-13 BR BRPI0614171-4A patent/BRPI0614171A2/pt not_active IP Right Cessation
- 2006-07-13 NZ NZ564685A patent/NZ564685A/en not_active IP Right Cessation
- 2006-07-13 KR KR1020097024108A patent/KR20090125294A/ko not_active Ceased
- 2006-07-13 AU AU2006273772A patent/AU2006273772A1/en not_active Abandoned
- 2006-07-13 AT AT06779913T patent/ATE524168T1/de not_active IP Right Cessation
- 2006-07-13 CN CNA2006800276994A patent/CN101232876A/zh active Pending
- 2006-07-13 WO PCT/IB2006/002081 patent/WO2007012963A1/en not_active Ceased
- 2006-07-25 JP JP2006201490A patent/JP2007031436A/ja active Pending
- 2006-07-25 AR ARP060103197A patent/AR054507A1/es not_active Application Discontinuation
- 2006-07-25 TW TW095127076A patent/TWI327472B/zh not_active IP Right Cessation
2007
- 2007-12-19 IL IL188268A patent/IL188268A0/en unknown
2008
- 2008-01-02 ZA ZA200800032A patent/ZA200800032B/xx unknown

Also Published As

Publication number	Publication date
IL188268A0 (en)	2008-04-13
AU2006273772A1 (en)	2007-02-01
TWI327472B (en)	2010-07-21
KR20080018278A (ko)	2008-02-27
RU2388461C2 (ru)	2010-05-10
RU2008101926A (ru)	2009-09-10
CN101232876A (zh)	2008-07-30
CA2616695A1 (en)	2007-02-01
US20110086086A1 (en)	2011-04-14
EP1909773A1 (en)	2008-04-16
MX2007016458A (es)	2008-03-07
NZ564685A (en)	2010-10-29
JP2007031436A (ja)	2007-02-08
CN101862310A (zh)	2010-10-20
BRPI0614171A2 (pt)	2011-03-15
TW200731974A (en)	2007-09-01
EP1909773B1 (en)	2011-09-14
KR20090125294A (ko)	2009-12-04
AR054507A1 (es)	2007-06-27
ATE524168T1 (de)	2011-09-15
CA2616695C (en)	2011-07-05
WO2007012963A1 (en)	2007-02-01

Publication	Publication Date	Title
ZA200800032B (en)	2009-09-30	Transdermal system for varenicline
IL278979A (en)	2021-01-31	Pharma-Informatics system
ZA200803882B (en)	2009-03-25	Transdermal Therapeutic System
EP2061261A4 (en)	2010-01-20	STEREO PROJECTION SYSTEM
EP2079414A4 (en)	2011-12-28	SYSTEM FOR CHEMOHYPER THERMAL TREATMENT
EP1961622A4 (en)	2015-04-01	DEVICE FOR ASSISTING TRAVEL IN SECURITY
PL1903946T3 (pl)	2016-07-29	System pobierania próbek
ZA200809004B (en)	2009-10-28	Autodestructive transdermal therapeutic system
EP1961641A4 (en)	2012-06-27	STEERING DEVICE
GB2431563B (en)	2010-04-28	Watersport hiking-support system
GB0511518D0 (en)	2005-07-13	Nofog system
GB2440253B (en)	2011-07-13	Equivalent time sampling system
GB0504771D0 (en)	2005-04-13	System
EP1833631A4 (en)	2012-07-11	AVERAGE POSITIONING
GB0518674D0 (en)	2005-10-19	System
GB2427760B (en)	2010-01-20	Antenna-transceiver system
HK1120435A (en)	2009-04-03	Transdermal therapeutic system
GB0509686D0 (en)	2005-06-15	Improved refigerating system
GB0519162D0 (en)	2005-10-26	System
GB0511217D0 (en)	2005-07-06	Overboarding system
GB0511197D0 (en)	2005-07-06	An ablation system
GB0510542D0 (en)	2005-06-29	Decking system
GB0510369D0 (en)	2005-06-29	Ratak hydraulic system
GB0505022D0 (en)	2005-04-20	Hydraulic system
HU3110U (en)	2006-05-29	Drink-sink device for box-drink